Associations of protein C and protein S with serum lipid concentrations

Size: px
Start display at page:

Download "Associations of protein C and protein S with serum lipid concentrations"

Transcription

1 British Journal of Haematology, 1998, 102, Associations of protein C and protein S with serum lipid concentrations P. K. M ACCALLUM, J.A.COOPER, J.MARTIN, D.J.HOWARTH, T.W.MEADE AND G. J. MILLER MRC Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, St Bartholomew s and the Royal London School of Medicine and Dentistry, London Received 18 November 1997; accepted for publication 16 April 1998 Summary. Difficulties in the laboratory measurement of protein C and protein S levels cause problems in the diagnosis of deficiency states in individual patients and may complicate estimation of the prevalence of these states in the general population. Some difficulties may be due to unappreciated influences affecting the measured levels of proteins C and S. We measured protein C activity and antigen, total and free protein S antigen, and serum total cholesterol, high-density cholesterol and triglyceride in a community-based study of 150 adults (73 male, 77 female), age range years. Participants were identified from the list of a single general practice by stratified random sampling within sex and decade of age. Protein C activity and antigen were strongly associated with serum lipids, mean levels increasing by approximately 0 25 u/ml as total cholesterol and triglyceride concentration each rose from the 5th to 95th centile. Total protein S antigen concentration was associated with total cholesterol, the mean rising by over 0 1 u/ml as total cholesterol increased from the 5th to the 95th centile, whilst a similar rise in triglyceride was associated with an increase in mean free protein S of more than 0 3 u/ml. Overall, physiological variation in total cholesterol and triglyceride concentration was associated with significant variation in protein C and protein S levels, independent of age and sex, suggesting that it is important to take serum lipids into account when investigating patients for protein C or protein S deficiency. Failure to do so may be misleading in some circumstances. Keywords: protein C, protein S, lipids, cholesterol, triglyceride. Protein C and protein S are vitamin-k-dependent naturally occurring anticoagulants whose physiological importance is evident from the association of heterozygous deficiencies of either with an increased risk of venous thromboembolism and of homozygous deficiencies with neonatal purpura fulminans (Lane et al, 1996a, b). A number of genetic and environment factors modulate protein C levels, including protein C promoter region polymorphisms, age, sex, ethnic group, body mass index and, possibly, the use of the combined oral contraceptive pill (Conlan et al, 1993; Tait et al, 1993; Dolan et al, 1994; Spek et al, 1995; Lowe et al, 1997; Woodward et al, 1997). Positive associations of protein C antigen with triglyceride, lowdensity (LDL) cholesterol and high-density (HDL) cholesterol were described in the population-based ARIC study (Conlan et al, 1993), and of protein C activity with total cholesterol and triglyceride in the third Glasgow MONICA Survey (Woodward et al, 1997). Both protein C antigen and activity Correspondence: Dr P. K. MacCallum, MRC Epidemiology and Medical Care Unit, Wolfson Institute of Preventive Medicine, St Bartholomew s and the Royal London School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ Blackwell Science Ltd were associated with triglyceride and total cholesterol in patients undergoing coronary angiography for angina pectoris (ECAT Angina Pectoris Study Group, 1993). In a recent population study, cholesterol and triglyceride were the most important predictors of protein C activity (Rodeghiero & Tosetto, 1996). However, in the PROCAM study, no independent association of protein C and triglyceride was found (Assmann & Schulte, 1992). There have been few reports of associations of protein S antigen with serum lipids, although positive associations of functional protein S with cholesterol and triglyceride were described in the third Glasgow MONICA Survey (Woodward et al, 1997). The existence of modulators of protein C and protein S levels may result in difficulties in the diagnosis of deficiency states in individual patients and may complicate estimation of the prevalence of these states in the general population. In a community-based study we have examined the associations of protein C and protein S with serum total cholesterol, HDL cholesterol and triglyceride and have found strong relationships with important practical implications for the diagnosis of protein C and protein S deficiency. 609

2 610 P. K. MacCallum et al SUBJECTS AND METHODS Participants and blood sampling. 166 adults were identified from the list of a general practice in South-East England by stratified random sampling on gender and decade of age. 150 subjects (73 males, 77 females) aged years agreed to take part (90% of the total). The mean age (range) was 55 7 (23 79) years for males and 52 1 (26 80) years for females. They attended the surgery at different times through the day, the majority (63%) during the morning between and hours. Venepunctures were performed using minimal stasis. Blood was collected into Vacutainer tubes containing no anticoagulant (for serum) or M citrate (9:1 vol:vol) and, for measurement of vitamin-k-dependent proteins, kept at room temperature until centrifugation. Serum and citrated plasma samples were centrifuged at room temperature for 10 min at 1500 g and stored at ¹70 C. Laboratory methods. Protein C activity was measured in microtitre plates by chromogenic assay (substrate S-2366, Chromogenix, Sweden) using Protac (Alpha Laboratories, U.K.) as the activator and an endpoint detection method. Protein C antigen was measured by modified Laurell electroimmunoassay (Tripodi & Mannucci, 1991) using antibodies from Dako, U.K. Modified Laurell electroimmunoassay (Tripodi & Mannucci, 1991), using antibodies from Dako, U.K., was also used to determine total and free protein S antigen concentration, the latter following 3 75% PEG 8000 precipitation at 4 C of C4BP-bound protein S. The protein C standard for activity and antigen was obtained from Immuno (U.K.) and standard curves were constructed using neat plasma and dilutions of 80%, 60%, 40%, 20% and 0%. A normal plasma pool obtained from 50 donors was used for the protein S standard and neat plasma and 1/2 and 1/4 dilutions were used for the standard curves. Tests were performed using neat plasma and all standards and tests were performed in duplicate. Total cholesterol, triglyceride and HDL cholesterol were measured using an Ektachem 250 (Johnson and Johnson, U.S.A.). Statistical methods. Variables were log-transformed where necessary to normalize the distributions and associations with age and sex were established. Associations of protein C and protein S with serum total cholesterol, HDL cholesterol and triglyceride were then individually examined after adjustment for age and sex. In the case of free protein S antigen, total protein S was also examined as an explanatory variable because free protein S reflects the molar excess of total protein S over C4BP (Griffin et al, 1992; Garcia de Frutos et al, 1994) and an association might therefore be expected. In the case of protein C, since there were significant univariate associations with more than one lipid variable, age, sex, total cholesterol, triglyceride and HDL cholesterol were all entered as independent explanatory variables in multiple regression models, and regression coefficients (standard errors) and partial correlation coefficients for each lipid variable were obtained. Five of the participants were taking the combined oral contraceptive pill and one was receiving hormone replacement therapy; they were excluded from the analysis although their results were not significantly different from the other females. RESULTS Protein C In females, protein C activity (r ¼ 0 37, P ¼ 0 002) and antigen (r ¼ 0 48, P < ) increased with age, though this was limited to those over 50 years, suggesting a menopausal effect. Thus, mean values in females for protein C activity were 0 89 u/ml under the age of 50 years and 1 04 u/ml for those over 50 years (P ¼ ). In males there was no significant association with age (r ¼ 0 14, P ¼ 0 25). Below the age of 50 years protein C levels tended to be lower in females than males, whereas the reverse was true in the over-50s. Protein C was log normally distributed and mean values are shown in Table I. Table I. Geometric mean [approx. SD] and (95% CI) levels in males and females (results adjusted to age 55 years). Males Females Protein C activity (u/ml) 0 97 [0 17] 0 99 [0 17] ( ) ( ) Protein C antigen (u/ml) 0 97 [0 15] 1 06 [0 21] ( ) ( ) Total protein S antigen (u/ml) 1 02 [0 11] 0 99 [0 16] ( ) ( ) Free protein S antigen (u/ml) 1 12 [0 29] 0 99 [0 30] ( ) ( ) Cholesterol (mmol/l) 5 3 [0 8] 5 74 [0 88] ( ) ( ) Triglyceride (mmol/l) 1 58 [0 76] 1 31 [0 68] ( ) ( ) HDL cholesterol (mmol/l) 1 22 [0 33] 1 48 [0 32] ( ) ( ) We then examined associations of protein C with serum lipids after adjustment for age and sex. Highly significant associations with total cholesterol and triglyceride were seen for both activity (Fig 1) and antigen. In multiple regression models which included age, sex and serum lipids as independent explanatory variables, protein C activity (Fig 2) and antigen were significantly and independently associated with total cholesterol and triglyceride but not with HDL cholesterol. A 1 0 mmol/l rise in serum total cholesterol (study normal range mmol/l) was associated with a 0 07 u/ml increase in both protein C activity and antigen. Thus, as cholesterol rose from the 5th to the 95th centile, mean protein C activity and antigen increased by 0 24 u/ml. A 1 0 mmol/l rise in triglyceride (study normal range mmol/l) was associated with a 0 09 u/ml increase in protein C activity and a 0 07 u/ml increase in protein C antigen. As triglyceride rose

3 Associations of Proteins C and S with Lipids 611 Fig 1. Scatter plots showing associations of protein C activity with (a) total cholesterol (r ¼ 0 57, P < ) and (b) triglyceride (r ¼ 0 55, P < ) after adjustment for age and sex (log/log scale). from the 5th to the 95th centile, mean protein C activity increased by 0 29 u/ml and mean protein C antigen by 0 22 u/ml. This slight difference was not significant (P ¼ 0 45). After adjustment for serum lipids the positive associations of protein C activity and antigen with age in females were no longer significant (r ¼ 0 02, P ¼ 0 84 for activity, r ¼ 0 15, P ¼ 0 21 for antigen). This indicated that the association of protein C with age largely represented confounding by levels of cholesterol and triglyceride. Total protein S antigen Total protein S antigen was normally distributed. Mean values are shown in Table I. There was an increase with age of borderline significance (r ¼ 0 23, P ¼ 0 06) in both males and females. Associations of total protein S antigen with serum lipids were examined after adjustment for age and sex. The only statistically significant association was with total cholesterol (Fig 3), a 1 0 mmol/l rise in total cholesterol being associated with a 0 04 u/ml rise in total protein S. As cholesterol rose from the 5th to the 95th centile, mean total protein S increased by 0 12 u/ml. Fig 2. Multiple regression model showing association of protein C activity with total cholesterol at the mean level (1 4 mmol/l) and 2 SD of triglyceride (log/log scale). For the association with total cholesterol, the partial correlation coefficient ¼ 0 34 and the slope of the regression line (b) ¼ 0 40 (SE 0 09), P < For the association with triglyceride, the partial correlation coefficient ¼ 0 36 and b ¼ 0 15 (0 03), P< Protein C activity can be calculated from the regression equation: log e protein C ¼¹0 65 þ 0 40 log e total cholesterol þ 0 15 log e triglyceride þ 0 09 log e HDL cholesterol ¹ 0 01 sex (if female) ¹ age.

4 612 P. K. MacCallum et al Fig 3. Association of (a) total protein S antigen with total cholesterol (r ¼ 0 23, b ¼ 0 20 (0 07), P ¼ 0 01) and (b) free protein S antigen with triglyceride (r ¼ 0 30, b ¼ 0 16 (0 04), P < ) after adjustment for age and sex (log/log scale). After adjustment for serum lipids, the association of total protein S antigen with age was no longer significant (r ¼ 0 10, P ¼ 0 23). Free protein S antigen The mean value of free protein S antigen (Table I) was significantly higher in males than females (P ¼ 0 007). Levels decreased with age in males (r ¼¹0 29, P ¼ 0 01). In females there was no significant linear effect of age (r ¼ 0 13, P ¼ 0 30). Since free protein S antigen is determined by the molar excess of total protein S over b-chain containing C4BP (Griffin et al, 1992; Garcia de Frutos et al, 1994), we examined the relationship between total and free protein S and found a strong positive association (r ¼ 0 30, P ¼ ) before and after adjustment for age and sex. As total protein S rose from the 5th to the 95th centile there was a 0 28 u/ml increase in mean free protein S antigen. We next examined the associations of free protein S with serum lipids after adjustment for age and sex. Free protein S was significantly associated with triglyceride (Fig 3) but not total or HDL cholesterol. A 1 0 mmol/l rise in triglyceride was associated with a 0 10 u/ml increase in free protein S antigen. As triglyceride rose from the 5th to the 95th centile, there was a 0 33 u/ml increase in mean free protein S antigen. The association between free protein S and triglyceride was independent of the association between total and free protein S antigen since it persisted (r¼ 0 28, P¼ 0 001) after adjustment for total protein S. Similarly, the association between total and free protein S was independent of their individual associations with serum lipids. Therefore the associations of triglyceride and total protein S with free protein S antigen were independent and very similar in overall effect. After adjustment for the association with lipids, the inverse association of free protein S antigen with age in males persisted (r ¼ ¹0 30, P ¼ 0 01). There was a significant difference in the associations of free protein S with age in the two sexes (P for interaction < 0 05). Serum lipids Mean levels are shown in Table I. Serum total cholesterol was log normally distributed. Cholesterol levels were higher in females (P ¼ 0 005) and increased with age (r ¼ 0 46, P < ). The age effect differed by sex, levels increasing more steeply with age in females than in males (P for

5 interaction ¼ 0 01). Serum triglyceride was log normally distributed and was higher in males (P ¼ 0 04). In females there was a significant increase with age (r ¼ 0 47, P < ) but in males there was no age effect (P ¼ 0 79). HDL cholesterol was log normally distributed. The mean level was significantly higher in females than in males (P < ), but did not change with age in either sex. DISCUSSION The prevalence of protein S deficiency in the general population is unclear and estimates for protein C deficiency have varied between studies (Miletich et al, 1987; Gladson et al, 1988; Tait et al, 1995). This uncertainty partly reflects difficulties in the laboratory diagnosis of deficiencies of these naturally occurring anticoagulants. Some of these problems may be due to hitherto unappreciated influences affecting the measured levels of proteins C and S. Difficulties may also occur in the clinical setting where levels of protein C or protein S are usually determined because there is an individual or family history of thrombosis. The problem in classifying individuals in family studies as having heterozygous protein C deficiency or not on the basis of their protein C levels was reported by Allaart et al (1993). They observed that 15% of genetically determined heterozygotes for protein C deficiency had protein C levels within the normal range whereas some of those without the identified genetic defect had reduced levels. To improve the separation of those with and without hereditary protein C deficiency, Tait et al (1993) recommended the use of age and sex related reference ranges for protein C in a study of nearly blood donors. Although an association between triglyceride and protein C levels has not clearly been shown in all population studies (Assmann & Schulte, 1992), data from the VITA project suggest that total cholesterol and triglyceride are the most important determinants of protein C activity (Rodeghiero & Tosetto, 1996). Our study, though smaller, is consistent with this finding and suggests that the previously described association of protein C with age in bigger cross-sectional studies largely reflects confounding by age-related changes in serum lipids. Variation in levels of serum lipids may therefore contribute to the difficulty in diagnosing heterozygous protein C deficiency. Thus, the overall study normal range (i.e. 2 SD from the mean) for protein C activity was u/ml. However, for those with cholesterol levels < 4 5 mmol/l (n ¼ 22) the range was u/ml, whereas for those with cholesterol > 6 5 mmol/l (n ¼ 18) it was u/ml. Associations of free and total protein S antigen include age, sex, pregnancy and use of the oestrogen-containing oral contraceptive pill (Boerger et al, 1987; Malm et al, 1988; Henkens et al, 1995). Determinants of protein S measured by a functional assay have been reported to include, amongst others, age, sex, use of the oral contraceptive pill or hormone replacement therapy (Lowe et al, 1997), total cholesterol, triglyceride and body mass index (Woodward et al, 1997). None of our participants was pregnant and the five taking the combined oral contraceptive pill and one on hormone replacement therapy were excluded from the analysis, Associations of Proteins C and S with Lipids 613 although their results were not significantly different from those of the remaining female participants. Inclusion of body mass index in the multiple regression models did not alter the associations of total and free protein S with serum lipids (data not shown). Total protein S antigen was significantly associated with cholesterol whereas free protein S antigen was associated with triglyceride levels. Total and free protein S antigen levels were strongly associated, as has been previously described (Griffin et al, 1992). The associations of triglyceride and total protein S with free protein S antigen were independent and similar in degree, with mean free protein S increasing by about 30% as triglyceride and total protein S each rose from the 5th to 95th centile. The normal range for males with triglyceride < 2 0 mmol/l was u/ml, whereas it was u/ml for those with triglyceride > 2 0 mmol/l. For females the ranges were u/ml and u/ml when the triglyceride levels were < and > 2 0 mmol/l, respectively. Classification of protein S deficiency is complicated by the distinction between free and bound forms of protein S and by lack of a reliable functional test. Deficiencies of both total and free (type I deficiency) and free protein S alone (type III deficiency) have been described within the same families (Zoller et al, 1995) and may be phenotypic variants of the same genetic disorder due to an age-related increase of total protein S (Simmonds et al, 1997). In our population we found a less striking increase of total protein S with age, which was largely due to confounding by the age-related increase in cholesterol. However, we also observed in males a reduction in free protein S with age which was independent of serum lipids. Conceivably part of the explanation for difficulties in classification of protein S deficiency in some instances could be the different associations of total and free protein S antigen levels with cholesterol and triglyceride as we have observed in our study of individuals without hereditary protein S deficiency. We collected samples from non-fasting subjects and the question arises as to whether the observed associations reflect acute post-prandial effects, a more chronic effect of lipid levels, or measurement artefact. Non-fasting samples may be more physiologically relevant than fasting samples because most time is spent in the non-fasting state and most samples in routine laboratories are collected from nonfasting individuals. Unpublished observations from our laboratory show no effect of a high fat meal on protein C and protein S antigen levels, despite elevation of triglyceride to concentrations as high as 8 mmol/l. This suggests that the associations are chronic rather than either an acute response to dietary fat or measurement artefact. As a consequence, the cross-sectional associations of protein C and protein S with triglyceride may have been underestimated, suggesting that there may be an advantage for diagnostic purposes in measuring levels in the fasting state. Triglyceride did not appear to have any significant spurious effect on the assay measurement of protein C activity because the increases in protein C activity and antigen with triglyceride were very similar and there was no change in the ratio of activity to antigen in the upper compared to the lower tertile of triglyceride (1 0 and 0 97 respectively,

6 614 P. K. MacCallum et al P ¼ 0 35). Likewise, the increases in protein C activity and antigen with cholesterol were virtually identical. Moreover, Tosetto et al (1997) for the VITA project recently provided data suggesting that the associations between lipids and protein C activity measured by chromogenic assay are unlikely to be due to a spurious laboratory effect of triglyceride or cholesterol. Even were such findings to be due to an in vitro effect they would still have important implications for individual patient diagnosis. In conclusion, physiological variations in levels of cholesterol and triglyceride are associated with clinically significant variations in measurements of protein C and protein S. Observed correlations based on single measurements are likely to be underestimates because of the regression dilution effect (MacMahon et al, 1990), reflecting the imprecision in the measurement of the variables due to biological and laboratory variability. The associations we have observed are nevertheless of sufficient size as to potentially influence the classification of protein C or protein S status in individuals. Indeed, failing to take account of such associations may not only be unhelpful but potentially misleading since, for example, a level of protein C activity of 0 80 u/ml would be well within our normal range for those with a cholesterol < 4 5 mmol/l, but below the normal range in those with a cholesterol of > 6 5 mmol/l. Likewise, a free protein S antigen level of 0 55 u/ml would be within the normal range for females with triglyceride < 2 0 mmol/l, but below that for those with triglyceride above this level. In the absence of facilities for genetic testing, which are not routinely available, it is important to be aware of these associations and, as has been suggested for protein C activity (Rodeghiero & Tosetto, 1996), to take them into account when interpreting results of individual testing or family screening in patients with possible deficiencies of protein C or protein S. Finally, we cannot exclude the possibility that the increases observed in protein C and protein S levels with increased serum lipid concentration are a response to changes in other variables rather than a direct effect of lipids. However, the association of these and other vitamin K- dependent proteins with cholesterol and triglyceride (Hoffman et al, 1994; Tracy et al, 1996;Woodwardet al, 1997) suggests some overlap in the regulation of their antigen concentrations and activities by lipids which may be of physiological and clinical significance. REFERENCES Allaart, C.F., Poort, S.R, Rosendaal, F.R., Reitsma, P.H., Bertina, R.M. & Briët, E. (1993) Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet, 341, Assmann, G. & Schulte, H. (1992) The importance of triglycerides: results from the Prospective Cardiovascular Münster (PROCAM) Study. European Journal of Epidemiology, 8, (Suppl. 1), Boerger, L.M., Morris, P.C., Thurnau, G.R., Esmon, C.T. & Comp, P.C. (1987) Oral contraceptives and gender affect protein S status. Blood, 69, Conlan, M.G., Folsom, A.R., Finch, A., Davis, C.E., Sorlie, P. & Wu, K.K. (1993) Correlation of plasma protein C levels with cardiovascular risk factors in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Thrombosis and Haemostasis, 70, Dolan, G., Neal, K., Cooper, P., Brown, P. & Preston, F.E. (1994) Protein C, antithrombin III and plasminogen: effect of age, sex and blood group. British Journal of Haematology, 86, ECAT Angina Pectoris Study Group. (1993) ECAT angina pectoris study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography. European Heart Journal, 14, Garcia de Frutos, P., Alim, R.I.M., Härdig, Y., Zöller, B. & Dahlbäck, B. (1994) Differential regulation of a and b chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S. Blood, 84, Gladson, C.L., Scharrer, I., Hach, V., Beck, K.H. & Griffin, J.H. (1988) The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thrombosis and Haemostasis, 59, Griffin, J.H., Gruber, A. & Fernandez, J.A. (1992) Reevaluation of total, free, and bound protein S and C4b-binding protein levels in plasma anticoagulated with citrate or hirudin. Blood, 79, Henkens, C.M.A., Bom, V.J.J., van der Schaaf, W., Pelsma, P.M., Sibinga, C.Th.S., de Kam, P.J. & van der Meer, J. (1995) Plasma levels of protein S, protein C, and factor X: effects of sex, hormonal state and age. Thrombosis and Haemostasis, 74, Hoffman, C.J., Lawson, W.E., Miller, R.H. & Hultin, M.B. (1994) Correlation of vitamin K-dependent clotting factors with cholesterol and triglycerides in healthy young adults. Arteriosclerosis and Thrombosis, 14, Lane, D.A., Mannucci, P.M., Bauer, K.A., Bertina, R.M., Bochkov, N.P., Boulyjenkov, V., Chandy, M., Dahlbäck, B., Ginter, E.K., Miletich, J.P., Rosendaal, F.R. & Seligsohn, U. (1996a) Inherited thrombophilia: Part 1. Thrombosis and Haemostasis, 76, Lane, D.A., Mannucci, P.M., Bauer, K.A., Bertina, R.M., Bochkov, N.P., Boulyjenkov, V., Chandy, M., Dahlbäck, B., Ginter, E.K., Miletich, J.P., Rosendaal, F.R. & Seligsohn, U. (1996b) Inherited thrombophilia: Part 2. Thrombosis and Haemostasis, 76, Lowe, G.D.O., Rumley, A., Woodward, M., Morrison, C.E., Philippou, H., Lane, D.A. & Tunstall-Pedoe, H. (1997) Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. British Journal of Haematology, 97, MacMahon, S., Peto, R., Cutler, J., Collins, R., Sorlie, P., Neaton, J., Abbott, R., Godwin, J., Dyer, A. & Stamler, J. (1990) Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet, 335, Malm, J., Laurell, M. & Dahlback, B. (1988) Changes in the plasma levels of vitamin K-dependent proteins C and S and of C4b-binding protein during pregnancy and oral contraception. British Journal of Haematology, 68, Miletich, J., Sherman, L. & Broze, G., Jr (1987) Absence of thrombosis in subjects with heterozygous protein C deficiency. New England Journal of Medicine, 317, Rodeghiero, F. & Tosetto, A. (1996) The VITA project: populationbased distributions of protein C, antithrombin III, heparincofactor II and plasminogen: relationship with physiological variables and establishment of reference ranges. Thrombosis and Haemostasis, 76, Simmonds, R.E., Zöller, B., Ireland, H., Thompson, E., de Frutos, P.G., Dahlbäck, B. & Lane, D.A. (1997) Genetic and phenotypic analysis of a large (122-member) protein S-deficient kindred provides an

7 explanation for the familial coexistence of type I and type III plasma phenotypes. Blood, 89, Spek, C.A., Koster, T., Rosendaal, F.R., Bertina, R.M. & Reitsma, P.H. (1995) Genotypic variation in the promoter region of the protein C gene is associated with plasma protein C levels and thrombotic risk. Arteriosclerosis, Thrombosis and Vascular Biology, 15, Tait, R.C., Walker, I.D., Islam, S.I.A.M., McCall, F., Conkie, J.A., Wight, M., Mitchell, R. & Davidson, J.F. (1993) Protein C activity in healthy volunteers: influence of age, sex, smoking and oral contraceptives. Thrombosis and Haemostasis, 70, Tait, R.C., Walker, I.D., Reitsma, P.H., Islam, S.I.A.M., McCall, F., Poort, S.R., Conkie, J.A. & Bertina, R.M. (1995) Prevalence of protein C deficiency in the healthy population. Thrombosis and Haemostasis, 73, Tosetto, A., Gatto, E. & Rodeghiero, F. (1997) Influence of cholesterol, triglycerides and fibrinogen on AT III, PC, HC-II and plasminogen measurement. Thrombosis and Haemostasis, 77, 804. Tracy, R.P., Losito, R., Howard, P., Cushman, M. & Bovill, E.G. (1996) The association of plasma lipids and vitamin K-dependent Associations of Proteins C and S with Lipids 615 coagulation factors. Nutrition, Genetics and Heart Disease (ed. by G. Bray and D. Ryan), pp Louisiana State University Press, Baton Rouge. Tripodi, A., & Mannucci, P.M. (1991) Laboratory diagnosis of proteins C and S. Blood Coagulation and Haemostasis: a Practical Guide (ed. by J. M. Thomson), 4th edn, pp Churchill Livingstone, Edinburgh. Woodward, M., Lowe, G.D.O., Rumley, A., Tunstall-Pedoe, H., Philippou, H., Lane, D.A. & Morrison, C.E. (1997) Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease. British Journal of Haematology, 97, Zöller, B., de Frutos, P.G. & Dahlbäck, B. (1995) Evaluation of the relationship between protein S and C4b-binding protein isoforms in hereditary protein S deficiency demonstrating type I and type III deficiencies to be phenotypic variants of the same genetic disease. Blood, 85,

Received 26 November 1996; accepted for publication 10 February 1997 RAPID PAPER

Received 26 November 1996; accepted for publication 10 February 1997 RAPID PAPER British Journal of Haematology, 1997, 97, 233 238 RAPID PAPER Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral

More information

Protein C and protein S levels can be accurately determined within 24 hours of diagnosis of acute venous thromboembolism

Protein C and protein S levels can be accurately determined within 24 hours of diagnosis of acute venous thromboembolism Clin. Lab. Haem. 2006, 28, 9 13 M. J. KOVACS*, J. KOVACS*, J. ANDERSON, M. A. RODGER, K. MACKINNON, P. S. WELLS Summary Keywords Protein C and protein S levels can be accurately determined within 24 hours

More information

Cover Page. The handle holds various files of this Leiden University dissertation

Cover Page. The handle   holds various files of this Leiden University dissertation Cover Page The handle http://hdl.handle.net/1887/37409 holds various files of this Leiden University dissertation Author: Engbers, Marissa Title: Conventional and age-specific risk factors for venous thrombosis

More information

THROMBOPHILIA SCREENING

THROMBOPHILIA SCREENING THROMBOPHILIA SCREENING Introduction The regulation of haemostasis Normally, when a clot occurs, it exactly occurs where it has to be and does not grow more than necessary due to the action of the haemostasis

More information

Molecular mechanisms & clinical consequences. of prothrombin mutations. A.J. Hauer

Molecular mechanisms & clinical consequences. of prothrombin mutations. A.J. Hauer Molecular mechanisms & clinical consequences of prothrombin mutations A.J. Hauer 07-12-2018 Prothrombin & the coagulation cascade Coagulation factor II, thrombin. Prothrombin is synthesized in the liver

More information

Comparison of Three Methods for Measuring Factor VIII Levels in Plasma

Comparison of Three Methods for Measuring Factor VIII Levels in Plasma Coagulation and Transfusion Medicine / THREE FACTOR VIII ASSAYS Comparison of Three Methods for Measuring Factor VIII Levels in Plasma Wayne L. Chandler, MD, Chris Ferrell, MT(ASCP), Joo Lee, MT(ASCP),

More information

Does sticky blood predict a sticky end? Associations of blood viscosity, haematocrit and fibrinogen with mortality in the West of Scotland

Does sticky blood predict a sticky end? Associations of blood viscosity, haematocrit and fibrinogen with mortality in the West of Scotland British Journal of Haematology, 2003, 122, 645 650 Does sticky blood predict a sticky end? Associations of blood viscosity, haematocrit and fibrinogen with mortality in the West of Scotland Mark Woodward,

More information

Polymorphisms in the protein C gene as risk factor for venous thrombosis

Polymorphisms in the protein C gene as risk factor for venous thrombosis CHAPTER 6 Polymorphisms in the protein C gene as risk factor for venous thrombosis Pomp ER, Doggen CJM, Vos HL, Reitsma PH, Rosendaal FR. Accepted for publication in Thrombosis and Haemostasis Chapter

More information

Haplotypes of VKORC1, NQO1 and GGCX, their effect on activity levels of vitamin K-dependent coagulation factors, and the risk of venous thrombosis

Haplotypes of VKORC1, NQO1 and GGCX, their effect on activity levels of vitamin K-dependent coagulation factors, and the risk of venous thrombosis Haplotypes of VKORC1, NQO1 and GGCX, their effect on activity levels of vitamin K-dependent coagulation factors, and the risk of venous thrombosis Haplotypes of VKORC1, NQO1 and GGCX, their effect on activity

More information

Determinants of the APTT- and ETP-based APC sensitivity tests

Determinants of the APTT- and ETP-based APC sensitivity tests Journal of Thrombosis and Haemostasis, 3: 1488 1494 ORIGINAL ARTICLE Determinants of the APTT- and ETP-based APC sensitivity tests M. C. H. DE VISSER,* A. VAN HYLCKAMA VLIEG,* G. TANS,à J. ROSING,à A.

More information

Laboratory Evaluation of Venous Thrombosis Risk

Laboratory Evaluation of Venous Thrombosis Risk Laboratory Evaluation of Venous Thrombosis Risk Dorothy M. Adcock, MD Volume 17, Number 12 December 2003 Objective: The reader will be able to discuss the concepts of risk factor, risk potential and thrombotic

More information

JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH

JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH How to cite this article: CHOWTA NITHYANANDA K, ARUN S, BIPIN P, FAZIL A. CHRONIC THROMBOEMBOLIC PULMONARY ARTERY HYPERTENSION WITH DEEP VEIN THROMBOSIS DUE

More information

Diagnosis and management of heritable thrombophilias

Diagnosis and management of heritable thrombophilias Link to this article online for CPD/CME credits Diagnosis and management of heritable thrombophilias Peter MacCallum, 1 2 Louise Bowles, 2 David Keeling 3 1 Wolfson Institute of Preventive Medicine, Barts

More information

Regular physical activity in leisure time is associated with

Regular physical activity in leisure time is associated with Physical Activity and Hemostatic and Inflammatory Variables in Elderly Men S. Goya Wannamethee, PhD; Gordon D.O. Lowe, MD; Peter H. Whincup, FRCP; Ann Rumley, PhD; Mary Walker, MA; Lucy Lennon, BSc Background

More information

Prevalence and Association of the Factor V Leiden and Prothrombin G20210A in Healthy Subjects and Patients with Venous Thromboembolism

Prevalence and Association of the Factor V Leiden and Prothrombin G20210A in Healthy Subjects and Patients with Venous Thromboembolism 42(4):488-492,2001 CLINICAL SCIENCES Prevalence and Association of the Factor V Leiden and Prothrombin G20210A in Healthy Subjects and Patients with Venous Thromboembolism Désirée Coen, Renata Zadro, Lorena

More information

ABC Fax Case Report. D. Gemmati M.L. Serino S. Moratelli S. Tognazzo A. Ongaro G.L.

ABC Fax Case Report. D. Gemmati M.L. Serino S. Moratelli S. Tognazzo A. Ongaro G.L. Case Report Haemostasis 2001;31:99 105 Received: October 10, 2000 Accepted after revision: April 5, 2001 Coexistence of Factor V G1691A and Factor II G20210A Gene Mutations in a Thrombotic Family Is Associated

More information

^ J a n e t K a l l o. ^ J u n e CLINICAL UTILITY OF PLASMA PROTEIN C MEASUREMENT

^ J a n e t K a l l o. ^ J u n e CLINICAL UTILITY OF PLASMA PROTEIN C MEASUREMENT ^ J a n e t K a l l o ^ J u n e 1 9 8 8 CLINICAL UTILITY OF PLASMA PROTEIN C MEASUREMENT TEST Plasma protein C, antigenic and functional activity measurement BACKGROUND Protein C is one of several known

More information

Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women

Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women European Heart Journal (998) 9, 55 6 as a risk factor for coronary heart disease and mortality in middle-aged men and women The Scottish Heart Health Study M. Woodward*, G. D. O. Lowe, A. Rumley and H.

More information

Thursday, February 26, :00 am. Regulation of Coagulation/Disseminated Intravascular Coagulation HEMOSTASIS/THROMBOSIS III

Thursday, February 26, :00 am. Regulation of Coagulation/Disseminated Intravascular Coagulation HEMOSTASIS/THROMBOSIS III REGULATION OF COAGULATION Introduction HEMOSTASIS/THROMBOSIS III Regulation of Coagulation/Disseminated Coagulation necessary for maintenance of vascular integrity Enough fibrinogen to clot all vessels

More information

G20210A prothrombin gene mutation identified in patients with venous leg ulcers

G20210A prothrombin gene mutation identified in patients with venous leg ulcers J.Cell.Mol.Med. Vol 5, No 4, 2001 pp. 397-401 G20210A prothrombin gene mutation identified in patients with venous leg ulcers Gh. Jebeleanu, Lucia Procopciuc * Department of Medical Biochemistry, University

More information

PhD, Mesut DEMIR, 1. MD, Mustafa DEMIRTAS, Murat ÇAYLI, 1 MD, Cumhur ALHAN, 1 MD, and Fikri BASLAMISLI,

PhD, Mesut DEMIR, 1. MD, Mustafa DEMIRTAS, Murat ÇAYLI, 1 MD, Cumhur ALHAN, 1 MD, and Fikri BASLAMISLI, Experimental Studies Prothrombin 20210GA and Factor V Leiden Mutations in Patients Less Than 55 Years Old With Myocardial Infarction Yurdaer DÖNMEZ, 1 MD, Mehmet KANADASI, 1 MD, Kahraman TANRIVERDI, 2,3

More information

Heritable thrombophilic disorders have been

Heritable thrombophilic disorders have been Does thrombophilia play an aetiological role in Legg-Calvé-Perthes disease? S. Hayek*, G. Kenet*, A. Lubetsky, N. Rosenberg, S. Gitel, S. Wientroub From Dana Children s Hospital, Tel-Aviv and the Sheba

More information

DEEP VENOUS THROMBOSIS AMONG CARRIERS OF FACTOR V LEIDEN AND THE G20210A PROTHROMBIN MUTATION

DEEP VENOUS THROMBOSIS AMONG CARRIERS OF FACTOR V LEIDEN AND THE G20210A PROTHROMBIN MUTATION DEEP VENOUS THROMBOSIS AMONG CARRIERS OF FACTOR V LEIDEN AND THE G20210A PROTHROMBIN MUTATION THE RISK OF RECURRENT DEEP VENOUS THROMBOSIS AMONG HETEROZYGOUS CARRIERS OF BOTH FACTOR V LEIDEN AND THE G20210A

More information

CEREBRAL-VEIN THROMBOSIS ASSOCIATED WITH A PROTHROMBIN-GENE MUTATION AND ORAL-CONTRACEPTIVE USE

CEREBRAL-VEIN THROMBOSIS ASSOCIATED WITH A PROTHROMBIN-GENE MUTATION AND ORAL-CONTRACEPTIVE USE CEREBRAL-VEIN ASSOCIATED WITH A PROTHROMBIN-GENE MUTATION AND ORAL-CONTRACEPTIVE USE HIGH RISK OF CEREBRAL-VEIN IN CARRIERS OF A PROTHROMBIN-GENE MUTATION AND IN USERS OF ORAL CONTRACEPTIVES IDA MARTINELLI,

More information

Prothrombin G20210A Gene Mutation and Further Prothrombotic Risk Factors in Childhood Thrombophilia

Prothrombin G20210A Gene Mutation and Further Prothrombotic Risk Factors in Childhood Thrombophilia Prothrombin G20210A Gene Mutation and Further Prothrombotic Risk Factors in Childhood Thrombophilia Ralf Junker, Hans-Georg Koch, Karin Auberger, Nicole Münchow, Silke Ehrenforth, Ulrike Nowak-Göttl, for

More information

Testing for genetic predisposition to venous thrombosis

Testing for genetic predisposition to venous thrombosis Testing for genetic predisposition to venous thrombosis By Marisa B. Marques, M.D. CONTINUING EDUCATION To earn CEUs, see test on page 20. LEARNING OBJECTIVES Upon completion of this article the reader

More information

Abnormally Short Activated Partial Thromboplastin Times Are Related to Elevated Plasma Levels of TAT, F1+2, D-Dimer and FVIII:C

Abnormally Short Activated Partial Thromboplastin Times Are Related to Elevated Plasma Levels of TAT, F1+2, D-Dimer and FVIII:C Pathophysiology of Haemostasis andthrombosis Original Paper Pathophysiol Haemost Thromb 2002;32:137 142 DOI: 10.1159/000065217 Received: January 28, 2002 Accepted in revised form: June 28, 2002 Abnormally

More information

An Unknown Genetic Defect Increases Venous Thrombosis Risk, through Interaction with Protein C Deficiency

An Unknown Genetic Defect Increases Venous Thrombosis Risk, through Interaction with Protein C Deficiency Am. J. Hum. Genet. 63:569 576, 998 An Unknown Genetic Defect Increases Venous Thrombosis Risk, through Interaction with Protein C Deficiency Sandra J. Hasstedt, Edwin G. Bovill, Peter W. Callas, 3 and

More information

Prevalence of Activated Protein C Resistance in Acute Myocardial Infarction in Japan

Prevalence of Activated Protein C Resistance in Acute Myocardial Infarction in Japan Clinical Studies Prevalence of Activated Protein C Resistance in Acute Myocardial Infarction in Japan Kazunori HAYASHI, MD, Takahito SONE,1 MD, Junichiro KONDOH,1 MD, Hideyuki TSUBOI,1 MD, Hiromi SASSA,1

More information

Thrombotic Variables and Risk of Idiopathic Venous Thromboembolism in Women Aged Years

Thrombotic Variables and Risk of Idiopathic Venous Thromboembolism in Women Aged Years Thromb Haemost 2000; 83: 530 5 2000 Schattauer Verlag, Stuttgart Thrombotic Variables and Risk of Idiopathic Venous Thromboembolism in Women Aged 45-64 Years Relationships to Hormone Replacement Therapy

More information

Inherited Thrombophilia Testing. George Rodgers, MD, PhD Kristi Smock MD

Inherited Thrombophilia Testing. George Rodgers, MD, PhD Kristi Smock MD Inherited Thrombophilia Testing George Rodgers, MD, PhD Kristi Smock MD Prevalence and risk associated with inherited thrombotic disorders Inherited Risk Factor % General Population % Patients w/ Thrombosis

More information

LUP. Lund University Publications Institutional Repository of Lund University

LUP. Lund University Publications Institutional Repository of Lund University LUP Lund University Publications Institutional Repository of Lund University This is an author produced version of a paper published in Journal of thrombosis and thrombolysis. This paper has been peer-reviewed

More information

Lipid Markers. Independent Risk Factors. Insulin Resistance Score by Lipid Fractionation

Lipid Markers. Independent Risk Factors. Insulin Resistance Score by Lipid Fractionation Patient: SAMPLE PATIENT DOB: Sex: MRN: 3701 CV Health Plus Genomics - Plasma, Serum & Buccal Swab Methodology: Chemiluminescent, Enzymatic, Immunoturbidimetric, NMR and PCR Lipid Markers Cholesterol LDL-

More information

Causative factors of deep vein thrombosis of lower limb in Indian population

Causative factors of deep vein thrombosis of lower limb in Indian population International Surgery Jthisnal Khadilkar R et al. Int Surg J. 18 Jan;(1):3-3 http://www.ijsurgery.com pissn 39-33 eissn 39-9 Original Research Article DOI: http://dx.doi.org/1.183/39-9.isj17919 Causative

More information

Optimal Utilization of Thrombophilia Testing

Optimal Utilization of Thrombophilia Testing Optimal Utilization of Thrombophilia Testing Rajiv K. Pruthi, MBBS Special Coagulation Laboratory & Comprehensive Hemophilia Center Division of Hematology/Internal Medicine Dept of Laboratory Medicine

More information

Genetics of Arterial and Venous Thrombosis: Clinical Aspects and a Look to the Future

Genetics of Arterial and Venous Thrombosis: Clinical Aspects and a Look to the Future Genetics of Arterial and Venous Thrombosis: Clinical Aspects and a Look to the Future Paul M Ridker, MD Eugene Braunwald Professor of Medicine Harvard Medical School Director, Center for Cardiovascular

More information

ORIGINAL PAPERS. Determinants of Elevated Levels of Natural Anticoagulants in Healthy Subjects*

ORIGINAL PAPERS. Determinants of Elevated Levels of Natural Anticoagulants in Healthy Subjects* ORIGINAL PAPERS Adv Clin Exp Med 205, 24, 5, 79 800 DOI: 0.729/acem/4436 Copyright by Wroclaw Medical University ISSN 899 5276 Barbara Kościelniak, B D, Ewa Wypasek 2, B D, Anetta Undas2,A, E, F Determinants

More information

Modifying effects of dietary polyunsaturated fatty acid (PUFA) on levels of cholesterol and their implications for heart health

Modifying effects of dietary polyunsaturated fatty acid (PUFA) on levels of cholesterol and their implications for heart health Modifying effects of dietary polyunsaturated fatty acid (PUFA) on levels of cholesterol and their implications for heart health Robert Clarke Clinical Trial Service Unit University of Oxford 28 th May

More information

Recent studies have found that elevated levels of coagulation

Recent studies have found that elevated levels of coagulation Elevated Hemostatic Factor Levels as Potential Risk Factors for Thrombosis Wayne L. Chandler, MD; George M. Rodgers, MD, PhD; Jason T. Sprouse, MD; Arthur R. Thompson, MD, PhD Recent studies have found

More information

Combined Factor V Leiden and Prothrombin Genotyping in Patients Presenting With Thromboembolic Episodes

Combined Factor V Leiden and Prothrombin Genotyping in Patients Presenting With Thromboembolic Episodes Combined Factor V Leiden and Prothrombin Genotyping in Patients Presenting With Thromboembolic Episodes John A. Friedline, MD; Ejaz Ahmad, MD; Diana Garcia, MD; Deborah Blue, MD; Noel Ceniza, MD; Joan

More information

The etiology, diagnosis and treatment of venous thromboembolism Kraaijenhagen, R.A.

The etiology, diagnosis and treatment of venous thromboembolism Kraaijenhagen, R.A. UvA-DARE (Digital Academic Repository) The etiology, diagnosis and treatment of venous thromboembolism Kraaijenhagen, R.A. Link to publication Citation for published version (APA): Kraaijenhagen, R. A.

More information

Thrombophilia. Diagnosis and Management. Kevin P. Hubbard, DO, FACOI

Thrombophilia. Diagnosis and Management. Kevin P. Hubbard, DO, FACOI Thrombophilia Diagnosis and Management Kevin P. Hubbard, DO, FACOI Clinical Professor of Medicine Kansas City University of Medicine and Biosciences-College of Osteopathic Medicine Kansas City, Missouri

More information

CONTENT SUPPLEMENTARY FIGURE E. INSTRUMENTAL VARIABLE ANALYSIS USING DESEASONALISED PLASMA 25-HYDROXYVITAMIN D. 7

CONTENT SUPPLEMENTARY FIGURE E. INSTRUMENTAL VARIABLE ANALYSIS USING DESEASONALISED PLASMA 25-HYDROXYVITAMIN D. 7 CONTENT FIGURES 3 SUPPLEMENTARY FIGURE A. NUMBER OF PARTICIPANTS AND EVENTS IN THE OBSERVATIONAL AND GENETIC ANALYSES. 3 SUPPLEMENTARY FIGURE B. FLOWCHART SHOWING THE SELECTION PROCESS FOR DETERMINING

More information

Are there still any valid indications for thrombophilia screening in DVT?

Are there still any valid indications for thrombophilia screening in DVT? Carotid artery stenosis and risk of stroke Are there still any valid indications for thrombophilia screening in DVT? Armando Mansilha MD, PhD, FEBVS Faculty of Medicine of University of Porto Munich, 2016

More information

Lower Contribution of Factor V Leiden or G Mutations to Ischemic Stroke in Patients With Clinical Risk Factors: Pair-Matched Case-Control Study

Lower Contribution of Factor V Leiden or G Mutations to Ischemic Stroke in Patients With Clinical Risk Factors: Pair-Matched Case-Control Study Lower Contribution of Factor V Leiden or G202104 Mutations to Ischemic Stroke in Patients With Clinical Risk Factors: Pair-Matched Case-Control Study Davor Eterović, PhD,* Marina Titlić, MD, Viktor Čulić,

More information

University of Groningen

University of Groningen University of Groningen The impact of a male or female thrombotic family history on contraceptive counseling van Vlijmen, E. F. W.; Veeger, Nicolaas; Middeldorp, S.; Hamulyak, K.; Prins, M. H.; Nelemans,

More information

Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors

Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors Ulrike Nowak-Göttl, Ralf Junker, Wolfhart Kreuz, Arnold

More information

Advances in understanding pathogenic mechanisms of thrombophilic disorders

Advances in understanding pathogenic mechanisms of thrombophilic disorders ASH 50th anniversary review Advances in understanding pathogenic mechanisms of thrombophilic disorders Björn Dahlbäck 1 1 Department of Laboratory Medicine, Section of Clinical Chemistry, Lund University,

More information

Guidelines for Shared Care Centres and Community Staff

Guidelines for Shared Care Centres and Community Staff Reference: CG1410 Written by: Dr Jeanette Payne Peer reviewer Dr Jenny Welch Approved: February 2016 Approved by D&TC: 8th January 2016 Review Due: February 2019 Intended Audience This document contains

More information

The Framingham Coronary Heart Disease Risk Score

The Framingham Coronary Heart Disease Risk Score Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Although

More information

Recurrent Venous Thrombo-Embolism in a Young Adult Female: Case Report with Review of Literature

Recurrent Venous Thrombo-Embolism in a Young Adult Female: Case Report with Review of Literature Cronicon OPEN ACCESS CARDIOLOGY Case Report Recurrent Venous Thrombo-Embolism in a Young Adult Female: Case Report with Review of Literature Ehab M Esheiba 1 *, Ani Purushothaman 2 1 Departments of Cardiology,

More information

HIGH FACTOR VIII, VON WILLEBRAND FACTOR, AND FIBRINOGEN LEVELS AND RISK

HIGH FACTOR VIII, VON WILLEBRAND FACTOR, AND FIBRINOGEN LEVELS AND RISK HIGH FACTOR VIII, VON WILLEBRAND FACTOR, AND FIBRINOGEN LEVELS AND RISK OF VENOUS THROMBOEMBOLISM IN BLACKS AND WHITES Venous thromboembolism (VTE) affects more than 300,000 people in the United States

More information

Impact of environmental and hereditary risk factors on the clinical manifestation of thrombophilia in homozygous carriers of factor V:G1691A

Impact of environmental and hereditary risk factors on the clinical manifestation of thrombophilia in homozygous carriers of factor V:G1691A Journal of Thrombosis and Haemostasis, 2: 430 436 ORIGINAL ARTICLE Impact of environmental and hereditary risk factors on the clinical manifestation of thrombophilia in homozygous carriers of factor V:G1691A

More information

Haemostasis, thrombosis risk and hormone replacement therapy

Haemostasis, thrombosis risk and hormone replacement therapy Haemostasis, thrombosis risk and hormone replacement therapy Serge Motte Brussels 13.05.17 - MY TALK TODAY The coagulation cascade and its regulation Effects of hormone replacement therapy on haemostasis

More information

Resistance to Activated Protein C, Factor V Leiden and the Prothrombin G20210A Variant in Patients with Colorectal Cancer

Resistance to Activated Protein C, Factor V Leiden and the Prothrombin G20210A Variant in Patients with Colorectal Cancer Pathophysiology of Haemostasis andthrombosis Original Paper Pathophysiol Haemost Thromb 2002;32:2 7 Received: December 8, 2000 Accepted in revised form: August 20, 2001 Resistance to Activated Protein

More information

Lipoprotein (a) Disclosures 2/20/2013. Lipoprotein (a): Should We Measure? Should We Treat? Health Diagnostic Laboratory, Inc. No other disclosures

Lipoprotein (a) Disclosures 2/20/2013. Lipoprotein (a): Should We Measure? Should We Treat? Health Diagnostic Laboratory, Inc. No other disclosures Lipoprotein (a): Should We Measure? Should We Treat? Joseph P. McConnell, Ph.D. DABCC Health Diagnostic Laboratory Inc. Baptist Health South Florida Eleventh Annual Cardiovascular Disease Prevention International

More information

Dave Duddleston, MD VP and Medical Director Southern Farm Bureau Life

Dave Duddleston, MD VP and Medical Director Southern Farm Bureau Life Dave Duddleston, MD VP and Medical Director Southern Farm Bureau Life Sources of Risk for Venous Diseases Pulmonary embolism (thrombus) Bleeding from anticoagulation Mortality from underlying disease Chronic

More information

Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden

Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden Clinical Policy Number: 05.01.03 Effective Date: January 1, 2016 Initial Review Date: July 15, 2015 Most Recent Review Date:

More information

ORIGINAL INVESTIGATION

ORIGINAL INVESTIGATION ORIGINAL INVESTIGATION Prothrombin 20210A A Mild Risk Factor for Venous Thromboembolism but Not for Arterial Thrombotic Disease and Pregnancy-Related Complications in a Family Study Ivan Bank, MD, PhD;

More information

Chapter. A higher risk of recurrent venous thrombosis in men is due to hormonal risk factors in women in thrombophilic families

Chapter. A higher risk of recurrent venous thrombosis in men is due to hormonal risk factors in women in thrombophilic families Chapter A higher risk of recurrent venous thrombosis in men is due to hormonal risk factors in women in thrombophilic families Willem M. Lijfering Nic J.G.M. Veeger Saskia Middeldorp Karly Hamulyák Martin

More information

Original Policy Date

Original Policy Date MP 2.04.71 Genetic Testing for Inherited Thrombophilia Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Created with literature search12:2013 Return to

More information

NQO1: Candidate gene in a quantitative trait locus affecting factor V and prothrombin levels

NQO1: Candidate gene in a quantitative trait locus affecting factor V and prothrombin levels NQO1: Candidate gene in a quantitative trait locus affecting factor V and prothrombin levels NQO1: Candidate gene in a quantitative trait locus affecting factor V and prothrombin levels Sara Roshani, Marieke

More information

Guidelines on cardiovascular risk assessment and management

Guidelines on cardiovascular risk assessment and management European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine

More information

Intermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis

Intermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis Intermediate Methods in Epidemiology 2008 Exercise No. 4 - Passive smoking and atherosclerosis The purpose of this exercise is to allow students to recapitulate issues discussed throughout the course which

More information

Should Patients with Venous Thromboembolism Be Screened for Thrombophilia?

Should Patients with Venous Thromboembolism Be Screened for Thrombophilia? REVIEW Should Patients with Venous Thromboembolism Be Screened for Thrombophilia? James E. Dalen, MD, MPH University of Arizona, Tucson. ABSTRACT In the mid-19th century, Virchow identified hypercoagulability

More information

Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden

Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden Clinical Policy Title: Genetic testing for G1691A polymorphism factor V Leiden Clinical Policy Number: 05.01.03 Effective Date: January 1, 2016 Initial Review Date: July 15, 2015 Most Recent Review Date:

More information

Venous Thrombosis: Prevalence and Interaction of Risk Factors

Venous Thrombosis: Prevalence and Interaction of Risk Factors Main Paper Haemostasis 1999;29(suppl 1)1-9 Venous Thrombosis: Prevalence and F.R. Rosendaal Umversity Hospital Leiden, Leiden, The Netherlands KeyWords Gene-gene interaction Gene-environment interaction

More information

Citation for published version (APA): van Vlijmen, E. F. W. (2016). The pill and thrombosis. [Groningen]: Rijksuniversiteit Groningen.

Citation for published version (APA): van Vlijmen, E. F. W. (2016). The pill and thrombosis. [Groningen]: Rijksuniversiteit Groningen. University of Groningen The pill and thrombosis van Vlijmen, Elizabeth Femma Willemien IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it.

More information

The New England Journal of Medicine

The New England Journal of Medicine The New England Journal of Medicine Medical Progress GENETIC SUSCEPTIBILITY TO VENOUS THROMBOSIS URI SELIGSOHN, M.D., AND AHARON LUBETSKY, M.D. THE annual incidence of venous thrombosis, one of the leading

More information

Genetics. Risk of Recurrent Venous Thrombosis in Homozygous Carriers and Double Heterozygous Carriers of Factor V Leiden and Prothrombin G20210A

Genetics. Risk of Recurrent Venous Thrombosis in Homozygous Carriers and Double Heterozygous Carriers of Factor V Leiden and Prothrombin G20210A Genetics Risk of Recurrent Venous Thrombosis in Homozygous Carriers and Double Heterozygous Carriers of Factor V Leiden and Prothrombin G20210A Willem M. Lijfering, MD, PhD; Saskia Middeldorp, MD, PhD;

More information

Agreement of Swiss-Adapted International and European Guidelines for the Assessment of Global Vascular Risk and for Lipid Lowering Interventions

Agreement of Swiss-Adapted International and European Guidelines for the Assessment of Global Vascular Risk and for Lipid Lowering Interventions DOI 10.1007/s10557-009-6162-y Agreement of Swiss-Adapted International and European Guidelines for the Assessment of Global Vascular Risk and for Lipid Lowering Interventions Michel Romanens & Franz Ackermann

More information

Risk of venous thromboembolism in users of non-oral contraceptives Statement from the Faculty of Sexual and Reproductive Healthcare

Risk of venous thromboembolism in users of non-oral contraceptives Statement from the Faculty of Sexual and Reproductive Healthcare Risk of venous thromboembolism in users of non-oral contraceptives Statement from the Faculty of Sexual and Reproductive Healthcare New data A paper published in May 2012 in the British Medical Journal

More information

Several methods have been devised for assessment of

Several methods have been devised for assessment of Comparison of Novel Hemostatic Factors and Conventional Risk Factors for Prediction of Coronary Heart Disease Jacqueline A. Cooper, MSc; George J. Miller, MD; Kenneth A. Bauer, MD; James H. Morrissey,

More information

PAI-1 Gene 4G/5G Genotype: A Risk Factor for Thrombosis in Vessels of Internal Organs

PAI-1 Gene 4G/5G Genotype: A Risk Factor for Thrombosis in Vessels of Internal Organs American Journal of Hematology 71:89 93 (2002) PAI-1 Gene 4G/5G : A Risk Factor for Thrombosis in Vessels of Internal Organs Gunay Balta,* Cigdem Altay, and Aytemiz Gurgey Hacettepe University, Faculty

More information

Decreased Levels of Protein C and Protein S in Patients with COPD and Pulmonary Embolism

Decreased Levels of Protein C and Protein S in Patients with COPD and Pulmonary Embolism The Open Atherosclerosis & Thrombosis Journal, 2012, 5, 29-33 29 Open Access Decreased Levels of Protein C and Protein S in Patients with COPD and Pulmonary Embolism Luis Maldonado Noriega 1 and Raúl Barrera

More information

C-reactive protein (CRP), a marker of the reactant plasma

C-reactive protein (CRP), a marker of the reactant plasma Thrombosis C-Reactive Protein, Fibrin D-Dimer, and Risk of Ischemic Heart Disease The Caerphilly and Speedwell Studies G.D.O. Lowe, P.M. Sweetnam, J.W.G. Yarnell, A. Rumley, C. Rumley, D. Bainton, Y. Ben-Shlomo

More information

Ischemic stroke is characterized by thrombotic occlusion of

Ischemic stroke is characterized by thrombotic occlusion of An Association Between Clotting Factor VII and Carotid Intima-Media Thickness The CARDIA Study David Green, MD, PhD; Nancy Foiles, MT; Cheeling Chan, MS; Joseph Kang, PhD; Pamela J. Schreiner, PhD; Kiang

More information

APC-PCI complex concentration is higher in patients with previous venous thromboembolism with Factor V Leiden.

APC-PCI complex concentration is higher in patients with previous venous thromboembolism with Factor V Leiden. APC-PCI complex concentration is higher in patients with previous venous thromboembolism with Factor V Leiden. Strandberg, Karin; Stenflo, Johan; Nilsson, C; Svensson, Peter Published in: Journal of Thrombosis

More information

The New England Journal of Medicine HIGH LEVELS OF COAGULATION FACTOR XI AS A RISK FACTOR FOR VENOUS THROMBOSIS

The New England Journal of Medicine HIGH LEVELS OF COAGULATION FACTOR XI AS A RISK FACTOR FOR VENOUS THROMBOSIS HIGH LEVELS OF COAGULATION FACTOR XI AS A RISK FACTOR FOR VENOUS THROMBOSIS JOOST C.M. MEIJERS, PH.D., WINNIE L.H. TEKELENBURG, M.SC., BONNO N. BOUMA, PH.D., ROGIER M. BERTINA, PH.D., AND FRITS R. ROSENDAAL,

More information

Menopausal Hormone Therapy & Haemostasis

Menopausal Hormone Therapy & Haemostasis Menopausal Hormone Therapy & Haemostasis The Haematologist Perspective Dr. Batia Roth-Yelinek Coagulation unit Hadassah MC Menopausal Hormone Therapy & Hemostasis Hemostatic mechanism Mechanism of estrogen

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle   holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/188/20915 holds various files of this Leiden University dissertation. Author: Flinterman, Linda Elisabeth Title: Risk factors for a first and recurrent venous

More information

Retinal vein occlusion and factor V Leiden and prothrombin G:A mutations

Retinal vein occlusion and factor V Leiden and prothrombin G:A mutations European Journal of Ophthalmology / Vol. 11 no. 4, 2001 / pp. 351-355 Retinal vein occlusion and factor V Leiden and prothrombin 20210 G:A mutations S. ARAS 1, G. YILMAZ 2, İ. ALPAS 1, V. BALTACI 1, E.

More information

The risk of recurrence in women with venous thromboembolism while using estrogens: a prospective cohort study

The risk of recurrence in women with venous thromboembolism while using estrogens: a prospective cohort study Journal of Thrombosis and Haemostasis, 12: 635 640 DOI: 10.1111/jth.12528 ORIGINAL ARTICLE The risk of recurrence in women with venous thromboembolism while using estrogens: a prospective cohort study

More information

THROMBOPHILIA TESTING: PROS AND CONS SHANNON CARPENTER, MD MS CHILDREN S MERCY HOSPITAL KANSAS CITY, MO

THROMBOPHILIA TESTING: PROS AND CONS SHANNON CARPENTER, MD MS CHILDREN S MERCY HOSPITAL KANSAS CITY, MO THROMBOPHILIA TESTING: PROS AND CONS SHANNON CARPENTER, MD MS CHILDREN S MERCY HOSPITAL KANSAS CITY, MO DISCLAIMER I m a pediatrician I will be discussing this issue primarily from a pediatric perspective

More information

In the NINCDS Stroke Data Bank, nearly 40%

In the NINCDS Stroke Data Bank, nearly 40% 1657 Free Protein S Deficiency: A Possible Association With Cerebrovascular Occlusion Ralph L. Sacco, MD, John Owen, MD, FRCPC, FIMLS, J.P. Mohr, MD, Thomas K. Tatemichi, MD, and Betty A. Grossman, BA

More information

Pathophysiology of Haemostasis andthrombosis. ABC Fax Original Paper

Pathophysiology of Haemostasis andthrombosis. ABC Fax Original Paper Pathophysiology of Haemostasis andthrombosis Original Paper Pathophysiol Haemost Thromb 2003;33:96 101 DOI: 10.1159/000073853 Received: August 20, 2002 Accepted after revision: April 7, 2003 Vascular Bed

More information

THE INCIDENCE RATE OF A FIRST

THE INCIDENCE RATE OF A FIRST ORIGINAL CONTRIBUTION Thrombophilia, Clinical Factors, and Recurrent Venous Thrombotic Events Sverre C. Christiansen, MD Suzanne C. Cannegieter, MD, PhD Ted Koster, MD, PhD Jan P. Vandenbroucke, MD, PhD

More information

Isolated protein S deficiency presenting as catastrophic systemic arterial and subsequently venous thrombosis

Isolated protein S deficiency presenting as catastrophic systemic arterial and subsequently venous thrombosis Isolated protein S deficiency presenting as catastrophic systemic arterial and subsequently venous thrombosis Sidhesh B Wagh, Ravi Anadure, Vijay Dutta, M.S.Sandhu, Rahul Trehan 1. Army Base Hospital Delhi

More information

Inflammatory markers and long-term risk of ischemic heart disease in men A 13-year follow-up of the Quebec Cardiovascular Study

Inflammatory markers and long-term risk of ischemic heart disease in men A 13-year follow-up of the Quebec Cardiovascular Study Atherosclerosis 182 (2005) 315 321 Inflammatory markers and long-term risk of ischemic heart disease in men A 13-year follow-up of the Quebec Cardiovascular Study Annie C. St-Pierre a,b, Bernard Cantin

More information

Jeanet M. Kemmeren, Ale Algra, Joost C. M. Meijers, Guido Tans, Bonno N. Bouma, Joyce Curvers, Jan Rosing, and Diederick E.

Jeanet M. Kemmeren, Ale Algra, Joost C. M. Meijers, Guido Tans, Bonno N. Bouma, Joyce Curvers, Jan Rosing, and Diederick E. HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor V Leiden mutation: a randomized

More information

The Multi-Factorial Threshold Model of Thrombotic Risk

The Multi-Factorial Threshold Model of Thrombotic Risk The Multi-Factorial Threshold Model of Thrombotic Risk Richard A. Marlar, PhD and Dorothy M. Adcock, MD The incidence of venous thrombosis in the US is between two and three million per year, resulting

More information

RECURRENT VENOUS THROMBOEMBOLISM AND MUTATION IN THE GENE FOR FACTOR V

RECURRENT VENOUS THROMBOEMBOLISM AND MUTATION IN THE GENE FOR FACTOR V THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM IN PATIENTS WITH AN Arg 506 Gln MUTATION IN THE GENE FOR FACTOR V (FACTOR V LEIDEN) PAOLO SIMIONI, M.D., PAOLO PRANDONI, M.D., PH.D., ANTHONIE W.A. LENSING,

More information

Evaluation Report: Eurolyser CRP test (ST0100 and ST0102) on. CUBE analyser (CA0100)

Evaluation Report: Eurolyser CRP test (ST0100 and ST0102) on. CUBE analyser (CA0100) Evaluation Report: Eurolyser CRP test (ST0100 and ST0102) on CUBE analyser (CA0100) Location Location: Eurolyser Diagnostica GmbH Operators: Simone Wieser; Franz Helminger; Michael Gruber Date: July-November

More information

Routine Tests of Haemostasis and Low-Oestrogen Oral Contraceptives: What to Expect?

Routine Tests of Haemostasis and Low-Oestrogen Oral Contraceptives: What to Expect? Clin. Lab. 2014;60:827-832 Copyright ORIGINAL ARTICLE Routine Tests of Haemostasis and Low-Oestrogen Oral Contraceptives: What to Expect? RENATA ZADRO 1 AND SANDRA OSLAKOVIC 2 1 Department of Laboratory

More information

CardioGenomicPlus Profile

CardioGenomicPlus Profile CardioGenomicPlus Profile Patient: SAMPLE PATIENT DOB: Sex: MRN: Apo E Chromosome 19 APOE APO E2: cys / cys APO E3: cys / arg APO E4: arg / arg The two SNPs lead to 3 possible variants for each chromosome,

More information

Multiple studies are available concerning the use of

Multiple studies are available concerning the use of SPECIAL ARTICLE Evaluation of the Biosite Ò Quantitative Whole Blood D-dimer Assay and Comparison With the biomérieux VIDAS Ò D-dimer Exclusion Test Validation and Utility For Use in the Central Laboratory

More information

The factor V Leiden mutation: Spectrum of thrombotic events and laboratory evaluation

The factor V Leiden mutation: Spectrum of thrombotic events and laboratory evaluation The factor V Leiden mutation: Spectrum of thrombotic events and laboratory evaluation Franklin A. Bontempo, MD, Andrea Cortese Hassett, PhD, Hawazin Faruki, DrPH, David L. Steed, MD, Marshall W. Webster,

More information

Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients

Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients ORIGINAL ARTICLES Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients Andrew C. Novick, MD, Safwat Zald, MD, David Goldfarb, MD, and Ernest E. Hodge, MD,

More information